Cadre just secured a five year FBI ballistic panel contract and raised its 2026 earnings guidance while authorizing a US$100 million buyback, yet the share chart tells a different story. Holding Cadre over the past year would have meant a 21.6% loss, including dividends. If you had bought on 10 November 2025, encouraged by optimistic discussion of nuclear safety platforms and government demand, what did the initial evidence really say about margins and insider selling risk?
Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.
If the move has made Cadre harder to judge, start where the gap is still open and scan 35 high quality undervalued stocks.
The Two Cadre Stories Investors Had To Hold In Mind
The shares cost US$43.32 at the start of the period, and anyone looking at Cadre then had to choose between two very different yet reasonable scripts.
On the bullish side, one scenario put Fair Value at US$50, about 15% above the start price, assuming 12.4% revenue growth and profit margins rising to 8.9% with a future P/E of 35.0x.
The more cautious script marked Fair Value at US$38.5, around 11% below the start price, assuming 11.2% revenue growth, 9.5% margins, and a future P/E of 26.1x while flagging contract delays and integration risk as live threats.
What The Results Changed For The Cadre Thesis
The FBI ballistic panel award and record orders backlog gave the bullish Cadre story fresh support on demand and contract wins. At the same time, margin pressure in early 2026 and a later Q3 2026 net margin of 7.9% against the 8.9% target showed profitability progress but still short of the more optimistic script. The evidence cut both ways.
The key lesson is simple. When a forecast leans on margin expansion, track net income and margin percentage in each report and weigh big contract headlines only after seeing what dropped to the bottom line.
What Today's Cadre Price Already Bakes In
Cadre trades at US$33.77 today after a 21.6% loss over the past year, and this bearish analyst Narrative on Simply Wall St still places its Fair Value above that quote based on record backlog and raised 2026 guidance.
The key hinge is whether demand for public safety and nuclear safety gear keeps supporting orders that management can convert into margins strong enough to justify that higher figure.
"The numbers imply the share price reflects scepticism that Cadre's record backlog, raised 2026 guidance, and ongoing M&A program will support the earnings power that a bullish view on the stock assumes over time."
One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all
Looking Beyond Cadre’s Contracts
Cadre’s contracts highlight how governments pay for protection on the ground. You could also look at what keeps critical gear working far above it.
Satellites, positioning systems and orbital hardware all depend on steady access to space. Without that, many high tech safety platforms never leave the drawing board.
One specialist launcher and hardware builder wants to handle rockets and the equipment they carry. Its aim is to become part of the basic space infrastructure customers build on.
If that effort works, heavier traffic into orbit could support demand for its hardware and services. If it falters, those ambitions stay stuck on the launch pad.
It is written up in full, assumptions and all. → Explore the Narrative that puts this company 56% above its price
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com